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Studies on P-glycoprotein expression and function have
revealed that a single nucleotide polymorphism (SNP) in
the human ABCB1 gene at 3435 (C > T) results in altered
expression and function of P-glycoprotein [1,2].There have
been reports of lower nelfinavir and efavirenz (EFV) con-
centrations associated with TT genotypes (mutant) of
ABCB1 C3435T polymorphism [3,4].Frequency distribution
of this polymorphism is known to vary across populations
[3, 5, 6]. We report the genotype distribution of ABCB1
C3435T in 179 individuals (126 HIV-infected and 53
healthy) from South India. The polymorphism was corre-
lated with plasma 12 h EFV and 2 h nevirapine (NVP) con-
centrations in 55 and 71 patients, respectively. Plasma EFV
and NVP were estimated by HPLC [7, 8]. Genotyping was
carried out by PCR-RFLP [9].
The number of TT, CT and CC genotypes, respectively,
were 78 (44%), 74 (41%) and 27 (15%); C and T allele fre-
quencies were 0.36 and 0.64, respectively. The difference
between observed and expected frequency was not sig-
nificant (P > 0.05) and satisfied Hardy–Weinberg equilib-
rium. This distribution is different from other populations;
TT genotypes in the South Indian population were 44%,
which is the highest reported so far (21–32% in Caucasians,
1–7% in Africans, 22% in Chinese, 20% in Japanese and
17% in Filipinos) [3, 5, 6]. The observed distribution was
significantly different from that reported by Schaeffeler
et al. [5] in Caucasian, African-American and Japanese
populations (P < 0.05). The distribution of this polymor-
phism was similar in patients and healthy subjects. A limi-
tation of this study was the small sample size. Hence, the
allele frequency of this polymorphism needs to be studied
in a larger population.
A trend in the plasma EFV concentrations was
observed. Patients with the CC genotype had the highest
values followed by CT and TT but the differences were not
statistically significant (Table 1). Similar findings have been
reported by others [3, 4]. Inter-individual variations in
plasma concentrations of EFV could be due to an indirect
effect of genetic variations in the ABCB1 gene.This is prob-
ably not theonly factor,sincemutations in theCYP2B6gene
could lead toalteredsubstrateutilization [10].Our studyhas
shown that plasma NVP did not differ between genotypes,
suggesting that NVP concentrations are not governed by
genetic variations in the ABCB1 gene (Table 1).
Differences in the distribution of the ABCB1 C3435T
polymorphism could impact on HIV-1 disease progression
as well as response to antiretroviral therapy in different
populations and this needs further study.
Table 1
Plasma EFV and NVP in different genotypes of the ABCB1 C3435T
polymorphism
Plasma concentration
(mean  SD (mg ml-1))
12 h EFV 2 h NVP
Total number of patients 55 71
Number of males 45 45
Mean age (range) (years) 37 (26–59) 34 (20–48)
CC genotype 5.22  5.32 8.33  2.78
(10) (11)
CT genotype 3.5  1.83 8.99  2.64
(22) (26)
TT genotype 2.48  1.29 7.52  2.65
(23) (34)
n given in parentheses.
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